Registro de Citas
Cita APA (7a ed.)
Lee, N., Chien, Y., Wang, C., Wong, S., Peng, S. S., Tsai, F., & Hwu, W. (2022). Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3. Elsevier.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Lee, Ni-Chung, Yin-Hsiu Chien, Chung-Hsing Wang, Siew-Lee Wong, Steven Shinn-Forng Peng, Fuu-Jen Tsai, y Wuh-Liang Hwu. Safety and Efficacy of Eliglustat Combined to Enzyme Replacement Therapy for Lymphadenopathy in Patients with Gaucher Disease Type 3. Elsevier, 2022.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Lee, Ni-Chung, et al. Safety and Efficacy of Eliglustat Combined to Enzyme Replacement Therapy for Lymphadenopathy in Patients with Gaucher Disease Type 3. Elsevier, 2022.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.